Valuation in Life Sciences

A Practical Guide

Valuation in Life Sciences

A Practical Guide

60,98 €*

lieferbar, sofort per Download

Falls Sie eine Lieferung außerhalb DE, AT oder CH wünschen, nutzen Sie bitte unser Kontaktformular für eine Anfrage.

This is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.


1;Foreword to the First Edition;52;Table of Contents;93;Abbreviations;124;Introduction;134.1;The Life Sciences Industry;144.2;Valuation;175;Fundamentals in Life Sciences;235.1;Drug Development;235.2;Medical Device Development and Approval;366;Basics of Valuation;396.1;Introduction;396.2;Fundamentals;396.3;Valuation Methods;577;Valuation in Life Sciences;957.1;Discounting;957.2;Volatility;997.3;Peak Sales;1027.4;Project Valuation;1167.5;License Contract Valuation;1597.6;Discovery and Preclinical License Deals: What's Realistic?;1837.7;Early-Stage Licensing with Possible Sublicensing;1857.8;Deconstructing Early-Stage Contracts;2107.9;Negotiating License Deals;2177.10;Bridging Different Assumptions in Licensing;2237.11;Valuing Projects with Multiple Indications;2277.12;Valuing Projects with Multiple Markets;2417.13;Technology Valuation and Feed Rate;2427.14;IP Valuation;2447.15;Pipeline Valuation;2527.16;Portfolio Management;2547.17;Company and Stock Valuation;2598;Exercises;2978.1;Introduction;2978.2;Exercises;2978.3;Solutions;3039;Case Studies;3239.1;Introduction;3239.2;Case Study 1: Creating a Term-Sheet for BT-100;3239.3;Case Study 1: Solutions;3289.4;Case Study 2: Bio-Tec's Lead Compound;3309.5;Case Study 2: Solutions;33510;References;33911;Index;341
ISBN 9783540782483
Artikelnummer 9783540782483
Medientyp E-Book - PDF
Auflage 2. Aufl.
Copyrightjahr 2008
Verlag Springer-Verlag
Umfang 334 Seiten
Sprache Englisch
Kopierschutz Adobe DRM